Warning! GuruFocus detected
1 Severe warning sign
with QUIA.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
QUIA PHARMA AB
SIC : 111
ISIN : SE0020678159
Compare
Compare
Traded in other countries / regions
QUIA.Sweden99B0.Germany IPO Date
2005-06-21Description
QUIA PHARMA AB is a development company for pharmaceuticals based on a patented drug delivery platform, Uni-Qleaver. The company develops improved and patentable forms of drugs under development or already approved by pharmaceutical authorities. These refined and enhanced forms of medicine are based on the Company's exceptional and patented technology platform. In addition to this, the Company offers multinational sales of omega-3, astaxin and collagen through Amazon.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.72 | |||||
| Piotroski F-Score | 4/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 90.4 | |||||
| 3-Year EPS without NRI Growth Rate | 87.5 | |||||
| 3-Year FCF Growth Rate | 92.2 | |||||
| 3-Year Book Growth Rate | -11.2 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 71.12 | |||||
| 9-Day RSI | 72.01 | |||||
| 14-Day RSI | 71.03 | |||||
| 3-1 Month Momentum % | -42.09 | |||||
| 6-1 Month Momentum % | -74.63 | |||||
| 12-1 Month Momentum % | -90.41 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.16 | |||||
| Quick Ratio | 0.16 | |||||
| Days Sales Outstanding | 34.18 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -891.4 | |||||
| Shareholder Yield % | -54.09 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 115.42 | |||||
| Operating Margin % | -1214.62 | |||||
| Net Margin % | -1225.81 | |||||
| FCF Margin % | -431.02 | |||||
| ROE % | -130.94 | |||||
| ROA % | -80.9 | |||||
| ROIC % | -65.69 | |||||
| 3-Year ROIIC % | -288.58 | |||||
| ROC (Joel Greenblatt) % | -14237.09 | |||||
| ROCE % | -129.74 | |||||
| Years of Profitability over Past 10-Year | 2 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 4.03 | |||||
| PB Ratio | 2.3 | |||||
| EV-to-EBIT | -1.98 | |||||
| EV-to-EBITDA | -5.83 | |||||
| EV-to-Revenue | 24.01 | |||||
| EV-to-FCF | -6.27 | |||||
| Earnings Yield (Greenblatt) % | -50.53 | |||||
| FCF Yield % | -28.15 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
QUIA PHARMA AB Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 2.36 | ||
| EPS (TTM) (kr) | -0.023 | ||
| Beta | 0.44 | ||
| 3-Year Sharpe Ratio | -0.9 | ||
| 3-Year Sortino Ratio | -1.19 | ||
| Volatility % | 163.29 | ||
| 14-Day RSI | 71.03 | ||
| 14-Day ATR (kr) | 0.003388 | ||
| 20-Day SMA (kr) | 0.007295 | ||
| 12-1 Month Momentum % | -90.41 | ||
| 52-Week Range (kr) | 0.003 - 0.10875 | ||
| Shares Outstanding (Mil) | 2,244.38 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
QUIA PHARMA AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
QUIA PHARMA AB Stock Events
| Event | Date | Price (kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
QUIA PHARMA AB Frequently Asked Questions
What is QUIA PHARMA AB(OSTO:QUIA)'s stock price today?
The current price of OSTO:QUIA is kr0.02. The 52 week high of OSTO:QUIA is kr0.11 and 52 week low is kr0.00.
When is next earnings date of QUIA PHARMA AB(OSTO:QUIA)?
The next earnings date of QUIA PHARMA AB(OSTO:QUIA) is 2025-08-29 Est..
Does QUIA PHARMA AB(OSTO:QUIA) pay dividends? If so, how much?
QUIA PHARMA AB(OSTO:QUIA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers